Ratings changes for Applied Digital, Invivyd, Advanced Micro Devices, Palantir Technologies, Palantir Technologies, Netflix, Palantir Technologies and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
While other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones.
And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares!
CAO Amie Thuener O’toole sold 1,340 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $202.08, for a total value of $270,787.20. Following the transaction, the chief accounting officer now owns 17,848 shares in the company, valued at approximately $3,606,723.84. This represents a 6.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
CEO Mark Zuckerberg sold 12,975 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $696.39, for a total transaction of $9,035,660.25. Following the completion of the sale, the chief executive officer now directly owns 210,971 shares in the company, valued at approximately $146,918,094.69. This trade represents a 5.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
AMC Entertainment (NYSE:AMC) was upgraded by analysts at Roth Mkm from a “sell” rating to a “neutral” rating. They now have a $3.25 price target on the stock, down previously from $4.00. This represents a 3.0% upside from the current price of $3.16.
Aptiv (NYSE:APTV) was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $77.00 price target on the stock, up previously from $63.00. This represents a 26.1% upside from the current price of $61.04.
Princeton Bancorp (NASDAQ:BPRN) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating. They now have a $35.00 price target on the stock. This represents a 10.6% upside from the current price of $31.65.
First Community (NASDAQ:FCCO) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating. They now have a $30.00 price target on the stock. This represents a 14.4% upside from the current price of $26.23.
Grab (NASDAQ:GRAB) was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $5.45 price target on the stock, down previously from $5.50. This represents a 6.5% upside from the current price of $5.12.
Juniper Networks (NYSE:JNPR) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $40.00 price target on the stock. This represents a 14.9% upside from the current price of $34.80.
Mastercard (NYSE:MA) was upgraded by analysts at DZ Bank AG from a “hold” rating to a “buy” rating. They now have a $620.00 price target on the stock. This represents a 10.9% upside from the current price of $558.89.
Marriott International (NASDAQ:MAR) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $330.00 price target on the stock. This represents a 13.8% upside from the current price of $289.91.
Novartis (NYSE:NVS) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating.The current price is $105.51.
News (NASDAQ:NWSA) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating.The current price is $28.42.
Palantir Technologies (NASDAQ:PLTR) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $95.00 price target on the stock, up previously from $60.00. This represents a 10.2% downside from the current price of $105.84.
Toyota Motor (NYSE:TM) was upgraded by analysts at Macquarie from a “neutral” rating to an “outperform” rating.The current price is $186.71.
Treace Medical Concepts (NASDAQ:TMCI) was upgraded by analysts at BTIG Research from a “neutral” rating to a “buy” rating. They now have a $16.00 price target on the stock. This represents a 56.6% upside from the current price of $10.22.
Tyson Foods (NYSE:TSN) was upgraded by analysts at Piper Sandler from an “underweight” rating to a “neutral” rating. They now have a $58.00 price target on the stock. This represents a 1.7% upside from the current price of $57.04.
Billionaire Sam Altman has become one of the most powerful men in the world by running OpenAI…
But there’s a far lesser known investment he’s making that could put OpenAI to shame.
In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI…
And the US Military… not to mention hundreds of other giant companies around the globe.
To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office…
Which ordered the government to take this incredible new technology seriously.
Autoliv (NYSE:ALV) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating. They now have a $100.00 price target on the stock, down previously from $109.00. This represents a 6.4% upside from the current price of $93.97.
Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $36.00 price target on the stock, down previously from $66.00. This represents a 8.8% upside from the current price of $33.09.
American Woodmark (NASDAQ:AMWD) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.The current price is $75.47.
Brilliant Earth Group (NASDAQ:BRLT) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $1.60 price target on the stock, down previously from $4.00. This represents a 5.3% downside from the current price of $1.69.
Calumet Specialty Products Partners (NASDAQ:CLMT) was downgraded by analysts at UBS Group AG from a “neutral” rating to a “sell” rating. They now have a $15.00 price target on the stock, down previously from $20.50. This represents a 11.0% downside from the current price of $16.86.
NIO (NYSE:NIO) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $4.70 price target on the stock. This represents a 5.5% upside from the current price of $4.45.
Napco Security Technologies (NASDAQ:NSSC) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $27.00 price target on the stock, down previously from $46.00. This represents a 3.8% upside from the current price of $26.02.
Napco Security Technologies (NASDAQ:NSSC) was downgraded by analysts at Craig Hallum from a “buy” rating to a “hold” rating. They now have a $28.00 price target on the stock. This represents a 7.6% upside from the current price of $26.02.
Ollie’s Bargain Outlet (NASDAQ:OLLI) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $111.00 price target on the stock, down previously from $125.00. This represents a 3.6% upside from the current price of $107.13.
Olin (NYSE:OLN) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating. They now have a $30.00 price target on the stock, down previously from $45.00. This represents a 6.9% upside from the current price of $28.07.
Reckitt Benckiser Group (OTCMKTS:RBGLY) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating.The current price is $13.19.
AnaptysBio (NASDAQ:ANAB) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $25.00 price target on the stock. This represents a 47.3% upside from the current price of $16.97.
Celestica (NYSE:CLS) (TSE:CLS) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $140.00 price target on the stock. This represents a 14.0% upside from the current price of $122.78.
Catalyst Pharmaceuticals (NASDAQ:CPRX) is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $28.00 price target on the stock. This represents a 23.6% upside from the current price of $22.66.
Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $39.23.
Equinox Gold (NYSEAMERICAN:EQX) is now covered by analysts at TD Cowen. They set a “hold” rating and a $35.00 price target on the stock. This represents a 438.9% upside from the current price of $6.50.
89bio (NASDAQ:ETNB) is now covered by analysts at Wolfe Research. They set an “outperform” rating on the stock.The current price is $9.52.
Chesapeake Energy (NASDAQ:EXE) is now covered by analysts at Raymond James. They set a “strong-buy” rating and a $135.00 price target on the stock. This represents a 29.5% upside from the current price of $104.23.
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $20.00 price target on the stock. This represents a 40.7% upside from the current price of $14.22.
Orla Mining (NYSEAMERICAN:ORLA) is now covered by analysts at TD Cowen. They set a “hold” rating on the stock.The current price is $6.31.
Plexus (NASDAQ:PLXS) is now covered by analysts at Stifel Nicolaus. They set a “hold” rating and a $152.00 price target on the stock. This represents a 9.1% upside from the current price of $139.32.
Rambus (NASDAQ:RMBS) is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $71.00 price target on the stock. This represents a 16.6% upside from the current price of $60.87.
Terreno Realty (NYSE:TRNO) is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $71.00 price target on the stock. This represents a 9.2% upside from the current price of $65.02.
Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $49.00 price target on the stock. This represents a 33.3% upside from the current price of $36.77.
Venture Global (NYSE:VG) is now covered by analysts at Sanford C. Bernstein. They set a “market perform” rating and a $20.00 price target on the stock. This represents a 3.8% downside from the current price of $20.79.
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $19.00 price target on the stock. This represents a 156.4% upside from the current price of $7.41.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
